In the present study, we demonstrated the changes of EGFR mutation of 45 NSCLC patients through AMPS PCR technology with tumor tissues, and monitored the EGFR mutation status by peripheral blood ctDNA. This evidence concerns the gene EGFR and non-small cell lung carcinoma.